Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819 for its Dose-2-Weight Syringe® and Safe-T-Dose® combinatorial drug injection kit. The Asepsis’ Calibrated Drug Delivery™(CDD) platform is designed to enhance dosing accuracy and eliminate crucial procedural tasks that are the leading cause of MAE’s during the preparation and administration of an injection. The CDD kits consolidate the correct components for a particular injection and are individually calibrated for the medication dosage strength, route of administration and patient characteristic. The calibrated components within the kit eliminate the need for consolidation, correlation and calculation procedures to correctly prepare and administer an injection. The overall features enhance the safety, accuracy and overall cost efficiency versus industry practice.
